Cargando...
New Drugs for Treating Dyslipidemia: Beyond Statins
Statins have been shown to be very effective and safe in numerous randomized clinical trials, and became the implacable first-line treatment against atherogenic dyslipidemia. However, even with optimal statin treatment, 60% to 80% of residual cardiovascular risk still exists. The patients with famil...
Guardado en:
| Publicado en: | Diabetes Metab J |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Korean Diabetes Association
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4411552/ https://ncbi.nlm.nih.gov/pubmed/25922802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2015.39.2.87 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|